vTv Therapeutics (VTVT) EV to FCF (2015 - 2026)

vTv Therapeutics has disclosed EV to FCF across 12 years of filings, most recently posting 33.26 for Q2 2026.

• In Q2 2026, EV to FCF fell 132.08% year-over-year to 33.26; the TTM figure through Jun 2026 stood at 22.78 (down 587.85% YoY), while the FY2025 annual figure was 9.87, down 452.67% from the prior year.
• EV to FCF came in at 33.26 for Q2 2026 at vTv Therapeutics, down from 43.05 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 103.75 in Q2 2022 to a low of 65.83 in Q1 2022.
• Average EV to FCF over 5 years is 7.33, with a median of 11.67 recorded in 2022.
• Year-over-year, EV to FCF tumbled 213.12% in 2025 and jumped 390.12% in 2026.
• Over 5 years, EV to FCF stood at 10.72 in 2022, then rose by 9.55% to 9.7 in 2023, then climbed by 3.27% to 9.38 in 2024, then slumped by 186.49% to 26.87 in 2025, then dropped by 23.77% to 33.26 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 33.26 in Q2 2026, 43.05 in Q1 2026, and 26.87 in Q4 2025.